<i>Momordica charantia</i> Suppresses Inflammation and Glycolysis in Lipopolysaccharide-Activated RAW264.7 Macrophages

Macrophage activation is a key event that triggers inflammatory response. The activation is accompanied by metabolic shift such as upregulated glucose metabolism. There are accumulating evidences showing the anti-inflammatory activity of <i>Momordica charantia</i>. However, the effects o...

Full description

Bibliographic Details
Main Authors: Shi Yan Lee, Won Fen Wong, Jiyang Dong, Kian-Kai Cheng
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/17/3783
_version_ 1797556913165041664
author Shi Yan Lee
Won Fen Wong
Jiyang Dong
Kian-Kai Cheng
author_facet Shi Yan Lee
Won Fen Wong
Jiyang Dong
Kian-Kai Cheng
author_sort Shi Yan Lee
collection DOAJ
description Macrophage activation is a key event that triggers inflammatory response. The activation is accompanied by metabolic shift such as upregulated glucose metabolism. There are accumulating evidences showing the anti-inflammatory activity of <i>Momordica charantia</i>. However, the effects of <i>M. charantia</i> on inflammatory response and glucose metabolism in activated macrophages have not been fully established. The present study aimed to examine the effect of <i>M. charantia</i> in modulating lipopolysaccharide (LPS)-induced inflammation and perturbed glucose metabolism in RAW264.7 murine macrophages. The results showed that LPS-induced NF-κB (p65) nuclear translocation was inhibited by <i>M. charantia</i> treatment. In addition, <i>M. charantia</i> was found to reduce the expression of inflammatory genes including <i>IL6</i>, <i>TNF-</i>α, <i>IL1</i>β, <i>COX2</i>, <i>iNOS</i>, and <i>IL10</i> in LPS-treated macrophages. Furthermore, the data showed that <i>M. charantia</i> reduced the expression of <i>GLUT1</i> and <i>HK2</i> genes and lactate production (−28%), resulting in suppression of glycolysis. Notably, its effect on <i>GLUT1</i> gene expression was found to be independent of LPS-induced inflammation. A further experiment also indicated that the bioactivities of <i>M. charantia</i> may be attributed to its key bioactive compound, charantin. Taken together, the study provided supporting evidences showing the potential of <i>M. charantia</i> for the treatment of inflammatory disorders.
first_indexed 2024-03-10T17:08:34Z
format Article
id doaj.art-321f8bd22a554980902cd8cf7f69699a
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T17:08:34Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-321f8bd22a554980902cd8cf7f69699a2023-11-20T10:42:43ZengMDPI AGMolecules1420-30492020-08-012517378310.3390/molecules25173783<i>Momordica charantia</i> Suppresses Inflammation and Glycolysis in Lipopolysaccharide-Activated RAW264.7 MacrophagesShi Yan Lee0Won Fen Wong1Jiyang Dong2Kian-Kai Cheng3Innovation Centre in Agritechnology, Universiti Teknologi Malaysia, Pagoh 84600, Johor, MalaysiaDepartment of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, MalaysiaDepartment of Electronic Science, Xiamen University, Xiamen 361005, ChinaInnovation Centre in Agritechnology, Universiti Teknologi Malaysia, Pagoh 84600, Johor, MalaysiaMacrophage activation is a key event that triggers inflammatory response. The activation is accompanied by metabolic shift such as upregulated glucose metabolism. There are accumulating evidences showing the anti-inflammatory activity of <i>Momordica charantia</i>. However, the effects of <i>M. charantia</i> on inflammatory response and glucose metabolism in activated macrophages have not been fully established. The present study aimed to examine the effect of <i>M. charantia</i> in modulating lipopolysaccharide (LPS)-induced inflammation and perturbed glucose metabolism in RAW264.7 murine macrophages. The results showed that LPS-induced NF-κB (p65) nuclear translocation was inhibited by <i>M. charantia</i> treatment. In addition, <i>M. charantia</i> was found to reduce the expression of inflammatory genes including <i>IL6</i>, <i>TNF-</i>α, <i>IL1</i>β, <i>COX2</i>, <i>iNOS</i>, and <i>IL10</i> in LPS-treated macrophages. Furthermore, the data showed that <i>M. charantia</i> reduced the expression of <i>GLUT1</i> and <i>HK2</i> genes and lactate production (−28%), resulting in suppression of glycolysis. Notably, its effect on <i>GLUT1</i> gene expression was found to be independent of LPS-induced inflammation. A further experiment also indicated that the bioactivities of <i>M. charantia</i> may be attributed to its key bioactive compound, charantin. Taken together, the study provided supporting evidences showing the potential of <i>M. charantia</i> for the treatment of inflammatory disorders.https://www.mdpi.com/1420-3049/25/17/3783bitter gourdcharantinmacrophageNF-κB translocationinflammation
spellingShingle Shi Yan Lee
Won Fen Wong
Jiyang Dong
Kian-Kai Cheng
<i>Momordica charantia</i> Suppresses Inflammation and Glycolysis in Lipopolysaccharide-Activated RAW264.7 Macrophages
Molecules
bitter gourd
charantin
macrophage
NF-κB translocation
inflammation
title <i>Momordica charantia</i> Suppresses Inflammation and Glycolysis in Lipopolysaccharide-Activated RAW264.7 Macrophages
title_full <i>Momordica charantia</i> Suppresses Inflammation and Glycolysis in Lipopolysaccharide-Activated RAW264.7 Macrophages
title_fullStr <i>Momordica charantia</i> Suppresses Inflammation and Glycolysis in Lipopolysaccharide-Activated RAW264.7 Macrophages
title_full_unstemmed <i>Momordica charantia</i> Suppresses Inflammation and Glycolysis in Lipopolysaccharide-Activated RAW264.7 Macrophages
title_short <i>Momordica charantia</i> Suppresses Inflammation and Glycolysis in Lipopolysaccharide-Activated RAW264.7 Macrophages
title_sort i momordica charantia i suppresses inflammation and glycolysis in lipopolysaccharide activated raw264 7 macrophages
topic bitter gourd
charantin
macrophage
NF-κB translocation
inflammation
url https://www.mdpi.com/1420-3049/25/17/3783
work_keys_str_mv AT shiyanlee imomordicacharantiaisuppressesinflammationandglycolysisinlipopolysaccharideactivatedraw2647macrophages
AT wonfenwong imomordicacharantiaisuppressesinflammationandglycolysisinlipopolysaccharideactivatedraw2647macrophages
AT jiyangdong imomordicacharantiaisuppressesinflammationandglycolysisinlipopolysaccharideactivatedraw2647macrophages
AT kiankaicheng imomordicacharantiaisuppressesinflammationandglycolysisinlipopolysaccharideactivatedraw2647macrophages